Literature DB >> 3706929

Osteoporosis in men with hyperprolactinemic hypogonadism.

S L Greenspan, R M Neer, E C Ridgway, A Klibanski.   

Abstract

To ascertain the effects of chronic hyperprolactinemia and testosterone deficiency on skeletal integrity in men, we measured forearm bone density and hormone concentrations in 18 men aged 30 to 79 who had prolactin-secreting pituitary tumors. We also measured vertebral bone density in 12 of the men. Patients with hyperprolactinemia had significant decreases in both forearm (p less than 0.001) and vertebral bone density (p = 0.003) compared with age-matched controls. Cortical osteopenia was significantly related to the duration of hyperprolactinemia (p less than 0.01) but not to the absolute levels of prolactin or androgens. Seven patients had longitudinal follow-up measurements of forearm bone density. Normalization of serum levels of prolactin or testosterone was associated with an increase in forearm bone density (p less than 0.05). These data show that chronic hyperprolactinemia and testosterone deficiency in men have deleterious and previously unrecognized extragonadal effects that may be alleviated after normalization of hormone concentrations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706929     DOI: 10.7326/0003-4819-104-6-777

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  46 in total

1.  Microprolactinoma: medical or surgical treatment as first line approach? The case for medical therapy.

Authors:  D A Rees; J S Davies; M F Scanlon
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

2.  Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.

Authors:  A Gürlek; O Gedik
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

3.  Osteoporosis in men.

Authors:  D C Anderson
Journal:  BMJ       Date:  1992-08-29

Review 4.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 5.  How to recognize late-onset hypogonadism in men with sexual dysfunction.

Authors:  Giovanni Corona; Giulia Rastrelli; Linda Vignozzi; Edoardo Mannucci; Mario Maggi
Journal:  Asian J Androl       Date:  2012-01-30       Impact factor: 3.285

6.  Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria.

Authors:  J E Zerwekh; K Sakhaee; N A Breslau; F Gottschalk; C Y Pak
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

7.  Prevalence of osteopenia in men with prolactinoma.

Authors:  E C O Naliato; M L F Farias; G R Braucks; F S R Costa; D Zylberberg; A H D Violante
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

8.  Post-traumatic hormonal disturbances: prolactin as a link between head injury and enhanced osteogenesis.

Authors:  R Wildburger; N Zarkovic; G Tonkovic; T Skoric; S Frech; M Hartleb; I Loncaric; K Zarkovic
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

Review 9.  Osteoporosis: cause and management.

Authors:  R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

10.  Prolactinoma presenting as chronic anaemia with osteoporosis: a case report.

Authors:  Fergus R Maclean; John P Hanley
Journal:  J Med Case Rep       Date:  2010-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.